| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
32,990,000 |
| Market
Cap: |
22.11(M) |
| Last
Volume: |
31,797 |
Avg
Vol: |
254,078 |
| 52
Week Range: |
$0.54 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Milestone Scientific is a biomedical technology research and development company. Co. has developed a proprietary, computer-controlled anesthetic delivery device, using The Wand®, a single use disposable handpiece. The device is marketed in dentistry under the trademark CompuDent®, and STA Single Tooth Anesthesia System® and in medicine under the trademark CompuMed®. CompuDent® is suitable for all dental procedures that require local anesthetic. CompuMed® is suitable for various medical procedures regularly performed in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics, and other disciplines.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
248,958 |
| Total Buy Value |
$0 |
$0 |
$0 |
$170,755 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
93,626 |
| Total Sell Value |
$0 |
$0 |
$0 |
$48,823 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Trombetta Giandomenico |
Director |
• • • |
2021-01-05 |
4 |
A |
$1.54 |
$9,000 |
D/D |
5,149 |
9,921,039 |
|
- |
|
| Osser Leonard |
Interim CEO |
• • – |
2021-01-05 |
4 |
S |
$2.25 |
$134,253 |
D/D |
(59,668) |
4,090,557 |
|
- |
|
| Osser Leonard |
Interim CEO |
• • – |
2021-01-04 |
4/A |
S |
$2.30 |
$72,169 |
D/D |
(31,378) |
4,190,733 |
|
- |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2021-01-04 |
4 |
S |
$2.20 |
$44,000 |
D/D |
(20,000) |
1,053,587 |
|
3% |
|
| Osser Leonard |
Interim CEO |
• • – |
2021-01-04 |
4 |
S |
$2.30 |
$165,338 |
D/D |
(71,886) |
4,150,225 |
|
3% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-29 |
4 |
S |
$1.96 |
$19,600 |
D/D |
(10,000) |
1,073,587 |
|
-21% |
|
| Schiller Leonard M |
Director |
• • – |
2020-12-29 |
4 |
A |
$1.96 |
$19,600 |
D/D |
10,000 |
286,470 |
|
- |
|
| Goldman Neal I |
Director |
• • – |
2020-12-29 |
4 |
A |
$1.96 |
$19,600 |
D/D |
10,000 |
822,570 |
|
- |
|
| Bernhard Leslie |
Director |
• • – |
2020-12-29 |
4 |
A |
$1.96 |
$29,400 |
D/D |
15,000 |
90,000 |
|
- |
|
| Mcgeehan Michael |
Director |
• • – |
2020-12-29 |
4 |
A |
$1.96 |
$19,600 |
D/D |
10,000 |
166,401 |
|
- |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-28 |
4 |
S |
$1.97 |
$39,400 |
D/D |
(20,000) |
1,083,587 |
|
-23% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-22 |
4 |
S |
$2.06 |
$20,600 |
D/D |
(10,000) |
1,013,587 |
|
-33% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-21 |
4 |
S |
$2.13 |
$21,300 |
D/D |
(10,000) |
1,113,587 |
|
-48% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-18 |
4 |
S |
$2.09 |
$20,900 |
D/D |
(10,000) |
1,123,587 |
|
-15% |
|
| Osser Leonard |
Interim CEO |
• • – |
2020-12-18 |
4 |
S |
$2.17 |
$118,211 |
D/D |
(54,400) |
4,139,123 |
|
-15% |
|
| Osser Leonard |
Interim CEO |
• • – |
2020-12-17 |
4 |
S |
$2.24 |
$36,512 |
D/D |
(16,300) |
4,193,523 |
|
-16% |
|
| Osser Leonard |
Interim CEO |
• • – |
2020-12-16 |
4 |
S |
$2.13 |
$154,425 |
D/D |
(72,500) |
4,209,823 |
|
-12% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-16 |
4 |
S |
$2.04 |
$20,400 |
D/D |
(10,000) |
1,133,587 |
|
-12% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-15 |
4 |
S |
$2.02 |
$20,200 |
D/D |
(10,000) |
1,143,587 |
|
-22% |
|
| Osser Leonard |
Interim CEO |
• • – |
2020-12-15 |
4 |
OE |
$1.14 |
$384,146 |
D/D |
336,970 |
4,282,323 |
|
- |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-14 |
4 |
S |
$1.92 |
$19,200 |
D/D |
(10,000) |
1,153,587 |
|
-28% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-11 |
4 |
S |
$1.86 |
$18,600 |
D/D |
(10,000) |
1,163,587 |
|
-32% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-09 |
4 |
S |
$1.88 |
$18,800 |
D/D |
(10,000) |
1,173,587 |
|
-34% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-08 |
4 |
S |
$1.84 |
$18,400 |
D/D |
(10,000) |
1,183,587 |
|
-24% |
|
| Dagostino Joseph |
CFO & COO |
• • – |
2020-12-07 |
4 |
S |
$1.85 |
$18,500 |
D/D |
(10,000) |
1,193,587 |
|
-34% |
|
342 Records found
|
|
Page 6 of 14 |
|
|
0.01 (1.3%) 
